Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
2,845 total articles
Geely (GELYF) shows constructive technicals and a sharp decline in short interest that support a tactical long. Enter at $2.34, stop at $2.05, primary target $2.70 over the next 45 trading days.
TripAdvisor has been beaten down to a sub-$10 stock after a string of near-term misses, but Starboard Value's 9% stake and push for a strategic review materially raise the odds of a re-rating. At an enterprise value of ~$1.24B, EV/EBITDA of 5.8x and free cash flow of $163M, the risk/reward favors a long swing trade while the activist process unfold…
Toast is a restaurant-focused SaaS and payments platform trading near $27.40. With guidance implying roughly $2.3B in ARR for 2026, $608M in free cash flow, and a healthy cash position, the bull case is simple: sustained net new locations and EBITDA expansion should drive multiple expansion from current EV/ARR levels. This trade idea recommends a l…
FLEX LNG's limited spot exposure and heavy dividend make it a tactical long as geopolitical friction around Iran lifts freight rates. The company is well-capitalized with $448M in cash and a $1.71B market cap, but technicals and rising shorts increase short-term risk. This trade targets $36 with a $28 stop over a mid-term (45 trading day) window.
Cboe Global Markets owns franchise assets tied directly to market activity and volatility. With record derivatives revenue traction, strong free cash flow and a modest payout, CBOE is a pragmatic hedge for portfolios anticipating higher volatility. We outline a mid-term trade with entry, stop and target, plus the key catalysts and risks to watch.
CACI is arguing it is misclassified as an IT services name. That dispute matters because a reclassification toward defense/aerospace peers could meaningfully change multiples. The company has solid fundamentals, recurring government revenue, recent M&A and contract wins, and technicals that support a mid-term long trade. Entry: $613.03. Stop: $585.…
Rio Tinto looks like a high-quality cyclical miner trading below near-term trendlines after the collapse of merger talks with Glencore. Fundamentals are intact: $108.8B market cap, a 4.2% yield, and exposure to rising copper demand plus new lithium investments. We upgrade to a buy and propose a mid-term swing trade with defined entry, target and st…
VALE S.A. looks priced for disappointment today despite a $67B market cap, a sub-2x price-to-book ratio, and an eye-catching dividend yield near 8.7%. Combine cyclical tailwinds for iron ore with durable nickel exposure for batteries, and the risk-reward favors a long position over the next 180 trading days. This trade plan includes a clear entry, …
Galiano Gold (GAU) shows technical oversold readings, falling short interest and steady volume after a soft stretch. The trade: enter near $2.29, stop $1.90, target $3.60, mid-term horizon (45 trading days). Thesis balances recovery signals against ongoing operational and macro risks.
Signet Jewelers is reporting resilient top-line and an exceptional free cash flow profile that, combined with a strategic pivot into lab-grown diamonds, makes the stock an appealing long. Valuation metrics (EV/EBITDA ~4.5, P/S ~0.47) and a FCF yield above 16% provide a margin of safety. The trade plan targets a retest of prior highs while protectin…
Verastem is trading at $5.82 with tangible clinical readouts and regulatory milestones looming into the first half of 2026. The balance sheet and enterprise value leave room for partner-led upside; we maintain Buy with a long-term trade plan to capture data-driven revaluation while limiting downside with a tight stop.
Copa Holdings (CPA) looks like a structurally profitable regional airline that has been punished in the short term. With a market cap near $4.56B, a P/E around 6.8, and a dividend yield close to 5.93%, the stock offers asymmetric upside if traffic and margins remain healthy. This trade idea lays out a clear entry at $111.00, a stop at $95.00 and a …
Brookfield Asset Management is seeing assets under management climb alongside a steady free cash flow profile and low leverage. The setup offers a mid-term opportunity to capture mean reversion toward prior valuation levels, with entry at $43.50, a stop at $40.00 and a $52.00 target over the next 45 trading days.
FactSet (FDS) is being punished in the market as investors extrapolate AI-driven disintermediation across financial services. That narrative discounts FactSet's subscription durability, 27.7% ROE, $647M in free cash flow and a sub-13x P/E. We recommend a tactical long for a mid-term rebound: enter at $207.49, stop $190.00, target $260.00 (45 tradin…
Alibaba reported a mixed quarter on 03/19/2026: revenue growth slowed to +2% while adjusted EBITA plunged 57%, but cloud intelligence revenue and AI product traction remain strong. The stock is trading oversold with a 14-day RSI ~26 and a market cap near $302B. I think this is a worthwhile long trade on weakness with defined entry, stop and a 180-t…
A pullback in private credit is reducing the ability of smaller chip startups and captive AI silicon projects to scale. That dynamic benefits incumbents that combine design scale, foundry relationships, and clean balance sheets. Advanced Micro Devices (AMD) checks those boxes: $6.7B free cash flow, near-zero leverage, and a market cap of roughly $3…
Abeona (ABEO) is a small-cap gene-therapy developer that now has an FDA-approved, autologous cell-based therapy - ZEVASKYN - for RDEB. With approval in hand and early payer coverage, the stock offers a high-risk, high-reward trade: entry at $4.53, stop at $3.70, target $8.00 over a 180 trading-day horizon.
Ichor reported an earnings beat and issued optimistic 2026 quarterly guidance, signaling margin recovery and sequential revenue growth. With a $1.68B market cap, improving short interest dynamics and low leverage, the stock has room to run. This trade idea outlines an actionable mid-term long with entry, stop and target levels and balanced risk con…
L'Oreal's recent share buyback, steady 2025 sales of €44.05 billion and a technically oversold ADR (RSI ~31) create a compelling setup for long-term investors. I upgrade the name to attractive for a long-term trade with a clear entry at $79.90, a stop at $70.00 and a target of $95.00 over the next 180 trading days.
Titan Machinery is trading cheaply relative to sales and book with strong free cash flow and an improving European franchise. Expect short-term pressure from margin compression and inventory rationalization, but the balance sheet and cash generation justify a tactical long for patient traders.
FMC is trading near its 52-week low after a brutal 2025. Management is exploring strategic alternatives, which creates a clear binary: a sale or renewed execution. This trade idea buys the rumor with a strict stop and a mid-term horizon to capture a potential takeover premium or short-covering rally while acknowledging the company’s negative earnin…
Twilio’s communications platform is showing durable adoption amid AI-driven product upgrades and improving expansion metrics. The company generates nearly $1.0B in free cash flow, carries modest leverage, and trades at a reasonable price-to-sales multiple for a growth software name. This idea buys a controlled pullback with a clear stop and a targe…
Adobe shares have sold off hard into 2026 on headlines - CEO transition, a $150M DOJ settlement and AI disruption fears - but fundamentals remain robust: ~$101B market cap, P/E ~14, free cash flow near $9.85B, and explicit AI partnerships that can re-accelerate revenue per seat. This trade idea takes a long stance over a 45-trading-day swing while …
Geron reported $184M of RYTELO revenue in 2025 and guided to $220-240M for 2026. The company carries roughly $400M in cash and has cut costs, yet valuation already prices slim growth. High short interest and upcoming commercial execution milestones create a technical and fundamental inflection that could push the stock higher. This trade lays out a…
POET Technologies is moving beyond proof-of-concept. Strategic partnerships with LITEON and Lessengers, confirmed prototype timelines, and fresh capital after a registered offering put optical interposer commercialization on the table. For traders, a defined long into late-2026 catalysts offers asymmetric upside versus a clear stop for dilution and…
